About: Off-patent Drugs Bill

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

The Off-patent Drugs Bill is a Bill introduced before the Parliament of the United Kingdom by Jonathan Evans in October 2014. It aims to make the British government seek new licences for off-patent medicines that could benefit patients whenever pharmaceutical companies fail to do so because there is no financial incentive. The bill's second reading order lapsed in December 2014. As a private member's bill (from an MP standing down in the 2015 General Election) it is unlikely to progress further. Passage of legislation on off-patent drugs has been supported by charities such as Breast Cancer Now. An Off-patent Drugs Bill was introduced as a PMB in the 2015 Parliament by Nick Thomas-Symonds MP.

Property Value
dbo:abstract
  • The Off-patent Drugs Bill is a Bill introduced before the Parliament of the United Kingdom by Jonathan Evans in October 2014. It aims to make the British government seek new licences for off-patent medicines that could benefit patients whenever pharmaceutical companies fail to do so because there is no financial incentive. The bill's second reading order lapsed in December 2014. As a private member's bill (from an MP standing down in the 2015 General Election) it is unlikely to progress further. Passage of legislation on off-patent drugs has been supported by charities such as Breast Cancer Now. An Off-patent Drugs Bill was introduced as a PMB in the 2015 Parliament by Nick Thomas-Symonds MP. (en)
dbo:wikiPageID
  • 45049205 (xsd:integer)
dbo:wikiPageLength
  • 1878 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082978973 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • The Off-patent Drugs Bill is a Bill introduced before the Parliament of the United Kingdom by Jonathan Evans in October 2014. It aims to make the British government seek new licences for off-patent medicines that could benefit patients whenever pharmaceutical companies fail to do so because there is no financial incentive. The bill's second reading order lapsed in December 2014. As a private member's bill (from an MP standing down in the 2015 General Election) it is unlikely to progress further. Passage of legislation on off-patent drugs has been supported by charities such as Breast Cancer Now. An Off-patent Drugs Bill was introduced as a PMB in the 2015 Parliament by Nick Thomas-Symonds MP. (en)
rdfs:label
  • Off-patent Drugs Bill (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License